Pulmatrix (PULM) Profit After Tax (2013 - 2026)
Pulmatrix (PULM) posted Profit After Tax of -$1.2 million for Q1 2026, down 26.29% sequentially from -$928000.0 in Q4 2025, and up 35.18% YoY from -$867011.5 in Q1 2025.
Pulmatrix (PULM) Profit After Tax (2013 - 2026) Analysis & Trends
Pulmatrix has reported Profit After Tax for 14 years, with the latest figure at -$1.2 million in Q1 2026.
- Quarterly Profit After Tax rose 35.18% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$4.5 million (up 62.88% YoY) and the FY2025 annual result came in at -$5.2 million, up 46.0% from the prior year.
- Profit After Tax eased to -$1.2 million in Q1 2026 per PULM's latest filing, from -$928000.0 in the prior quarter.
- Over five years, Profit After Tax peaked at $825000.0 in Q1 2024 and troughed at -$5.8 million in Q2 2024.
- A 5-year average of -$2.9 million and a median of -$2.6 million in 2024 frame the typical range for Profit After Tax.
- The sharpest annual moves came in 2024 and 2025: Profit After Tax surged 118.55% in 2024, then plunged 319.15% in 2025.
- Over 5 years, Profit After Tax stood at -$4.2 million in 2022, then surged by 50.59% to -$2.1 million in 2023, then rose by 4.66% to -$2.0 million in 2024, then soared by 53.27% to -$928000.0 in 2025, then dropped by 26.29% to -$1.2 million in 2026.
- According to Business Quant data, Profit After Tax over the past three periods registered -$1.2 million, -$928000.0, and -$877000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 1.10 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.30 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 472.00 Mn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -782.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 237.01 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 164.49 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -355.03 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -16.62 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 81.49 Mn |
| 10 | Pulmatrix | 5.46 Mn | 5.46 Mn | - | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -1.04 Mn |
| Mar 31, 2026 | -1.17 Mn |
| Dec 31, 2025 | -928,000.00 |
| Sep 30, 2025 | -877,000.00 |
| Jun 30, 2025 | -1.55 Mn |
| Mar 31, 2025 | -1.81 Mn |
| Dec 31, 2024 | -1.99 Mn |
| Sep 30, 2024 | -2.59 Mn |
| Jun 30, 2024 | -5.81 Mn |
| Mar 31, 2024 | 825,000.00 |
| Dec 31, 2023 | -2.08 Mn |
| Sep 30, 2023 | -3.77 Mn |
| Jun 30, 2023 | -3.82 Mn |
| Mar 31, 2023 | -4.45 Mn |
| Dec 31, 2022 | -4.22 Mn |
| Sep 30, 2022 | -5.05 Mn |
| Jun 30, 2022 | -4.60 Mn |
| Mar 31, 2022 | -4.97 Mn |
| Dec 31, 2021 | -4.03 Mn |
| Sep 30, 2021 | -8.18 Mn |